Project 170399
Application of User-Centered Participatory Design Research in the Development of an Online Intervention to Provide Social Support to Parents of Adolescents with Diabetes
Application of User-Centered Participatory Design Research in the Development of an Online Intervention to Provide Social Support to Parents of Adolescents with Diabetes
Project Information
| Study Type: | Trial Randomized_Controlled_Trial |
| Therapeutic Area: | Infectious_Disease |
| Research Theme: | Social / Cultural / Environmental / Population Health |
| Disease Area: | tuberculosis prevention |
| Data Type: | Global |
Institution & Funding
| Principal Investigator(s): | Paterson, Barbara L |
| Co-Investigator(s): | Amirault, Debra D; Gutwin, Carl; Holtslander, Lorraine F; Letourneau, Nicole L; Mandryk, Regan L; Nicholas, David B; Stamler, Lynnette L |
| Institution: | University of New Brunswick (Fredericton) |
| CIHR Institute: | Human Development, Child and Youth Health |
| Program: | |
| Peer Review Committee: | Social & Developmental Aspects of Children's & Youth's Health |
| Competition Year: | 2008 |
| Term: | 2 yrs 0 mth |
Abstract Summary
Adolescence is a time when children with type 1 diabetes may resist parental involvement in their diabetes management but at the same time, they may neglect aspects of their self-management. Parents of adolescents with type 1 diabetes typically experience a number of stressors during this period, particularly in relation to making the transition between the main decision maker to assuming a minor role in regard to the child's diabetes management.The research is intended to design and develop an online social support intervention to assist parents in such a transition. It will draw on research approaches that entail working with parents of children with diabetes, service providers and web designers to develop a web-based intervention that meets the needs for social support of parents of adolescents with diabetes.
Research Characteristics
This project includes the following research characteristics:
Study Justification
"evaluate the effectiveness of rifampin vs isoniazid for latent tuberculosis infection"
Novelty Statement
"comparing 4 months rifampin with 9 months isoniazid for effectiveness in preventing active TB"
Methodology Innovation
comparison of different treatment durations for latent TB